Bond.az White LogoBond.az Black Logo

Citizens Raises Rithm Capital Price Target

Citizens raises Rithm Capital price target to $13.50, highlighting asset growth and a shift to asset management. RITM offers a 11.11% dividend yield.

Mia Lopez
ByMia Lopez- Senior Editor
|
0

Citizens raised its price target on Rithm Capital Corp. (NYSE:RITM) to $13.50 from $12.50 while maintaining a Market Outperform rating. The stock currently trades at $9, suggesting significant upside potential.

The firm established co-coverage between its Mortgage Finance and Alternative Asset Management research teams. Rithm acquired Sculptor Capital Management in late 2023, marking a move into alternative asset management.

Later, the company became the external manager of publicly traded mortgage REIT Rithm Property Trust and acquired Crestline Management in late 2025. Rithm's asset management segment now has $59 billion in assets under management.

Mortgage origination and servicing remains the largest segment at roughly 45% of equity. Asset management is second at 18%, followed by commercial real estate at 18%, the investment portfolio at 12%, and the Genesis residential transition loan business at 7%. Notably, the company offers an exceptional 11.11% dividend yield and has paid dividends for 14 consecutive years.

Citizens said the co-coverage is appropriate given management's strategic focus on asset management. Rithm Capital recently reported Q1 2026 earnings that surpassed expectations, with EPS of $0.51 versus $0.50 forecast, and revenue of $1.38 billion against $1.25 billion expected.

More News
2026-06-01 12:02
|
743

Legend Biotech Buy Rating Reiterated

H.C. Wainwright reiterated its Buy rating for Legend Biotech with a $50 target. Revenue up 56% over twelve months.

0
2026-06-01 12:01
|
475

Cogent Stock Price Target Raised to $55

Cogent Biosciences PEAK trial: combination therapy shows 45.6% response rate, 16.5 months PFS, FDA accepts NDA. H.C. Wainwright raises price target to $55.

0
2026-06-01 12:00
|
842

H.C. Wainwright Reaffirms Mineralys Buy

H.C. Wainwright reiterated a Buy rating on Mineralys Therapeutics with a $56 price target after positive trial data.

0
2026-06-01 10:33
|
714

Goldman Sachs Upgrades Marriott Vacations Stock

Goldman Sachs upgrades Marriott Vacations stock to Buy, price target $100. Execution potential drives earnings upside.

0
2026-06-01 10:32
|
730

Goldman Sachs Upgrades Travel + Leisure Stock to Buy

Goldman Sachs upgraded Travel + Leisure stock to Buy with a $85 price target. Learn about the company's financials, dividends, and market outlook.

0
2026-06-01 10:32
|
238

Canaccord Initiates Rare Earths Americas with Buy

Canaccord Genuity initiates Rare Earths Americas with a buy rating and $25 target. Stock at $21.85, offering 14% upside potential.

0
2026-06-01 10:30
|
651

BofA Raises Icon Stock Target to $125 on Bookings

BofA Securities raised Icon plc price target to $125, maintains Underperform. Improved booking trends and Q4 results drive revision.

0
2026-06-01 10:03
|
748

RBC Capital: Sprouts faces Kroger risk

RBC Capital keeps Sprouts rating but sees risks from Kroger price cuts. Analysis and outlook on Bond.az.

0
2026-06-01 09:02
|
551

CLSA Rates Chagee Hold on Margins

CLSA initiated Chagee Holdings with Hold rating and $10 target. Bond.az analysis reveals stock may be undervalued. Read more.

0
2026-06-01 08:31
|
594

Barclays Downgrades Sensata Stock on Valuation

Barclays downgrades Sensata stock to Equalweight on valuation concerns, but raises price target to $53. Stock surged 92% in past year.

0
2026-06-01 08:05
|
946

UBS Initiates Veritone Coverage with Neutral

UBS initiated coverage on Veritone with a Neutral rating and $2.50 price target. The AI company is better positioned for growth after transformation.

0
2026-06-01 08:02
|
892

JMP Securities Initiates Microsoft with Outperform on AI Strategy

JMP Securities initiates Microsoft with Market Outperform rating and $550 target on AI strategy. Revenue growth expected to reach 17% in FY2026.

0
...
Citizens Raises Rithm Capital Price Target | Bond.az